Their study demonstrated that miR-203a-3p overexpression decreased angiogenesis and reduced HIF-1α and VEGFA levels in hyperglycemia-stimulated HRMECs and showed that the decreased miR-203a-3p level could be reversed by MALAT1 silencing. Here, MALAT1 is linked to Hyperglycemia.